Literature DB >> 30128667

Geographic distribution of anti-Leptospira antibodies in humans in Côte d'Ivoire, West Africa.

Stephane Kouadio Koffi1,2, Syndou Meite3, Abdoulaye Ouattara3, Stephane Kan Kouassi3, Sylla Aboubacar3, Veronique Agbaya Akran3, Pascale Bourhy4, Mireille Dosso3.   

Abstract

Leptospirosis is a zoonotic bacterial disease with a worldwide importance, mostly frequent in tropical and subtropical countries. In Côte d'Ivoire, little is known about leptospirosis and human data are sparse. This disease is usually misdiagnosed with other febrile illnesses, and determining high-risk areas could allow better management of this disease, leading to policies. This study aims to map leptospirosis exposure areas by determining geographic distribution of anti-Leptospira antibodies in humans in Côte d'Ivoire. A total of 384 serum samples were randomly selected in the national surveillance system for communicable diseases in 2014. All the 82 health districts were include in the study. Serums were screened by ELISA at Institut Pasteur de Côte d'Ivoire and confirmed by MAT in the National Reference Centre for leptospirosis in Institut Pasteur in Paris. In these samples, ELISA screened 90 specimens showing anti-Leptospira antibodies and 36 specimens were confirmed by MAT (9.4%). Observed cases were mostly located in health districts of the western and the southern parts of the country. People with anti-Leptospira antibodies had a mean age of 34.5 years old and a sex ratio of 2. This pattern corresponds to active low-income farmers working into agricultural fields. This study reveals circulation of leptospirosis in human population in Côte d'Ivoire. The disease seems to be more frequent in the western and the southern parts of the country. Active low-income farmers working into agricultural fields without personal protective gear could be one of the most at-risk populations.

Entities:  

Keywords:  Antibodies; Côte d’Ivoire; Epidemiology; Leptospirosis

Mesh:

Substances:

Year:  2018        PMID: 30128667     DOI: 10.1007/s10096-018-3359-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

Review 1.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Serological survey of canine leptospirosis in three countries of tropical Africa: Sudan, Gabon and Ivory Coast.

Authors:  Cédric Roqueplo; Jean-Lou Marié; Geneviève André-Fontaine; Angeli Kodjo; Bernard Davoust
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2014-11-01       Impact factor: 2.268

3.  Sensitivity of pathogenic and free-living Leptospira spp. to UV radiation and mitomycin C.

Authors:  L V Stamm; N W Charon
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

Review 4.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

Review 5.  Global Morbidity and Mortality of Leptospirosis: A Systematic Review.

Authors:  Federico Costa; José E Hagan; Juan Calcagno; Michael Kane; Paul Torgerson; Martha S Martinez-Silveira; Claudia Stein; Bernadette Abela-Ridder; Albert I Ko
Journal:  PLoS Negl Trop Dis       Date:  2015-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.